Paper Details

  1. Home
  2. Paper Details

Etanercept for treating axial spondyloarthritis.

Author: GuillotXavier, PratiClément, SondagMaxime, WendlingDaniel

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This review summarizes the efficacy and tolerance of etanercept in treating axial spondyloarthritis (Ax-SpA). Etanercept, a TNF blocker, demonstrated efficacy on axial and peripheral manifestations of Ax-SpA, exhibiting good tolerance and drug survival rates. However, the review highlights the need for further research to better define the role of etanercept in Ax-SpA treatment strategies.
Paper Details　
Original Abstract of the Article :
Axial spondyloarthritis is an inflammatory rheumatic disease causing back pain, functional impairment and potential ankylosis in the advanced stage. In this context, TNF blockers have been a major therapeutic advance. Etanercept is a soluble recombinant TNF receptor fusion protein in this vain. Area...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14712598.2017.1347156

データ提供：米国国立医学図書館（NLM）

Etanercept: A Therapeutic Advance for Axial Spondyloarthritis

This research explores the therapeutic potential of [etanercept] in the treatment of [axial spondyloarthritis], a debilitating inflammatory disease that affects the spine. The study delves into the efficacy and safety profile of [etanercept] in managing both the [axial] and [peripheral] manifestations of this complex condition. This research provides valuable insights into the role of [etanercept] as a therapeutic agent within the broader landscape of [axial spondyloarthritis] treatment.

Etanercept Shows Promise in Axial Spondyloarthritis Treatment

This research demonstrates that [etanercept] has shown clinical efficacy in managing both the [axial] and [peripheral] manifestations of [axial spondyloarthritis]. This study highlights the potential of [etanercept] as an effective therapeutic option for patients with this debilitating disease, potentially offering relief from pain, functional impairment, and disease progression. This research also suggests that [etanercept] may be well-tolerated, with good drug survival rates observed over time.

Navigating the Treatment Options for Axial Spondyloarthritis

This research underscores the importance of individualized treatment approaches in [axial spondyloarthritis], taking into account the unique needs and circumstances of each patient. It provides valuable information for healthcare professionals seeking to make informed decisions about the best course of treatment for their patients. The study also emphasizes the need for further research to fully understand the long-term impact of [etanercept] on [radiographic progression] in [axial spondyloarthritis].

Dr.Camel's Conclusion

This research offers a glimmer of hope in the desert of [axial spondyloarthritis]. [Etanercept] emerges as a promising therapeutic agent, potentially offering relief from the debilitating symptoms of this disease. Just as a camel navigates the harsh desert landscape with resilience and determination, this research provides a roadmap for navigating the challenges of [axial spondyloarthritis], guiding us towards a better understanding of this complex condition and its treatment.
Date :
  1. Date Completed 2017-12-06
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28682112

DOI: Digital Object Identifier

10.1080/14712598.2017.1347156

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.